GEODE CAPITAL MANAGEMENT, LLC - GEMINI THERAPEUTICS INC ownership

GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 2 filers reported holding GEMINI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of GEMINI THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$446,000
-2.6%
272,271
+0.4%
0.00%
Q2 2022$458,000
-23.5%
271,115
-37.1%
0.00%
Q1 2022$599,000
-53.5%
431,325
-2.6%
0.00%
Q4 2021$1,289,000
-32.6%
442,967
-6.5%
0.00%
Q3 2021$1,913,000
-34.9%
473,735
+4.3%
0.00%
Q2 2021$2,938,000
-22.7%
454,195
+61.9%
0.00%
-100.0%
Q1 2021$3,801,000280,5450.00%
Other shareholders
GEMINI THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Foresite Capital Management V, LLC 2,435,125$9,838,0003.06%
Asymmetry Capital Management, L.P. 284,079$1,148,0000.69%
Orbimed Advisors 5,826,224$23,538,0000.26%
Boxer Capital, LLC 1,300,000$5,252,0000.18%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,137,823$8,637,0000.15%
Ikarian Capital, LLC 421,050$1,701,0000.12%
JS Capital Management LLC 474,457$1,917,0000.11%
PURA VIDA INVESTMENTS, LLC 494,400$1,997,0000.06%
HARVARD MANAGEMENT CO INC 250,000$1,010,0000.06%
Atom Investors LP 102,792$415,0000.03%
View complete list of GEMINI THERAPEUTICS INC shareholders